2013 CPhI Pharma Awards - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

2013 CPhI Pharma Awards


CPhI is now accepting applications for the 2013 CPhI Pharma Awards, open to individuals and companies who have developed innovations in pharma over the past year.

About the Awards
For nine years, the CPhI Pharma Awards have recognized thought leadership on a global scale, unveiling top pharma innovators to global trade press during the leading pharmaceutical event.

Learn more about the Awards
Benefits of Entering

Finalists will be notified in September 2013, and will present their innovations on the CPhI show floor on Oct. 22, 2013. The CPhI Pharma Awards ceremony and party are scheduled for the evening of Oct. 22 in the Messe Frankfurt Europa Room.

Categories
Awards are presented in three categories:
Innovation in Formulation
Entries in the Innovation in Formulation category should pertain to the following topics: Drug Delivery, Excipients, Controlled Release, Stability, or Bio Availability.

Innovation in Process Development
Entries in the Innovation in Process Development category should pertain to the following topics: Synthesis, Crystalization, Polymorphism, Catalysts or Green Chemistry.

Innovation in Packaging
Entries in the Innovation in Packaging category should pertain to the following topics: Primary Packaging, Devices & Technology, Patient Compliance, Dispensers, Materials, Counterfeit Technologies.

Learn more about the categories.

Entry Process

The CPhI Pharma Awards are open for pharmaceutical professionals working in roles spanning the entire pharma industry. CPhI Worldwide 2013 exhibitors can enter free of charge. Registered visitors can enter with a €95 application fee. Entrants must submit the appropriate application by Friday, July 26, 2013.

For more information, visit www.cphi.com/awards.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here